INTRODUCTION
============

Mitochondrial transport from mother to daughter (bud) during asymmetric cell division in *Saccharomyces cerevisiae* ensures that the healthiest organelles are inherited by the new generation ([@B37]; [@B46]). This inheritance is critical, as buds lacking mitochondria do not separate from the mother and thus cannot survive independently ([@B36]; [@B23]). This process is mediated by the type V myosin motor Myo2, which transports mitochondrial membranes along actin cables into the bud ([@B2]; [@B20]). Two additional proteins, Ypt11 and Mmr1, interact with the cargo-binding domain on the Myo2 tail and participate in mitochondrial inheritance ([@B30], [@B29]; [@B17]). Although Mmr1 colocalizes with mitochondria ([@B29]; [@B54]), Ypt11 does not, raising questions about how Ypt11 promotes mitochondrial partitioning.

Ypt11 is a Rab GTPase implicated in the bud-directed movement of multiple organelles. Although initially linked to mitochondrial inheritance, subsequent studies showed it also functions in the transport of cortical endoplasmic reticulum (cER) and late Golgi membranes into yeast buds ([@B10]; [@B3]; [@B22]). Curiously, Ypt11 localization studies are not entirely consistent with these functions. Different studies have reported Ypt11 on the perinuclear and cortical ER ([@B10]), as well as at the bud tip and mother--bud neck ([@B30]). Several scenarios could explain how Ypt11 acts on mitochondria. A small (undetected) fraction of cellular Ypt11 could associate directly with the organelle and recruit the Myo2 motor to the membrane. Alternatively, the effect of Ypt11 on mitochondrial distribution could be indirect. A protein complex called ER mitochondria encounter structure (ERMES) was recently shown to mediate direct physical contact between the yeast ER and mitochondria ([@B33]). ERMES complexes were observed moving from the mother cell into the bud during division ([@B40]). Thus it is theoretically possible that mitochondria "hitch a ride" with ER membranes that are actively transported during cell division. It has also been proposed that, instead of recruiting Myo2 to mitochondria, Ypt11 mediates bud-directed transport of a factor or factors associated with the cER and/or Golgi, which anchor mitochondria in the daughter cell ([@B44]; [@B54]).

Although initially characterized as regulators of membrane trafficking and fusion, members of the Rab GTPase family also act directly in membrane transport by tethering vesicles and organelles to motor proteins ([@B49]; [@B27]). Consistent with its organelle inheritance function, Ypt11 is the only yeast Rab that displays periodic transcription, with expression peaking during the G1 phase of the cell cycle, immediately before bud emergence ([@B14]; [@B52]; [@B45]). Ypt11 function may also be posttranscriptionally regulated, since proteomic studies indicate that Ypt11 is phosphorylated ([@B1]; [@B7], [@B8]; [@B26]). In addition, Ypt11 contains unique sequence features not found in other Rabs. Whether and how these sequence features and protein modifications contribute to Ypt11 function in vivo, and specifically in mitochondrial inheritance, are not known.

In this study, we explore the relationship between Ypt11 expression level and cellular localization. We present new evidence that Ypt11 acts directly on mitochondria, rather than indirectly through ER--mitochondrial connections, to promote mitochondrial inheritance. We describe a novel interaction between Ypt11 and Mmr1, indicating that the activities of these two Myo2-binding partners may be physically coordinated in vivo. Our studies also reveal an uncommon mode of Rab regulation in which phosphorylation status and degradation contribute to the selective turnover of active forms of the Ypt11 GTPase.

RESULTS
=======

The N-terminus of Ypt11 contributes to mitochondrial inheritance
----------------------------------------------------------------

The *YPT11* sequence initially deposited in genomic databases was missing 185 nucleotides at the 5′ end of the gene (*Saccharomyces* Genome Database \[[www.yeastgenome.org/](http://www.yeastgenome.org/)\], *YNL304W* Locus History). As a result, initial studies on Ypt11 either used the shorter sequence ([@B30]) or potentially both short and long versions of the sequence ([@B10]). Subsequent studies used the updated sequence with the 5′ extension ([@B3]; [@B17]). This 5′ extension creates two potential initiation codons for the Ypt11 protein (Met1 or Met63, [Figure 1A](#F1){ref-type="fig"}). Members of the Rab superfamily typically contain a short (up to 20 amino acids \[aa\]) variable region N-terminal to the conserved GTPase domain. In the case of Ypt11, translation initiation at Met-63 would generate an N-terminus of comparable length (28-aa variable region). By contrast, initiation at Met-1 would add 62 aa to this variable region (90-aa variable region). As described later, we used two complementary approaches to determine whether the longer N-terminus was important for Ypt11 function. This analysis was performed in a *ypt11*Δ *mmr1*Δ strain. Although Ypt11 and Mmr1 are not essential, mitochondrial transport into buds is delayed when either of the proteins is absent, and cells lacking both proteins have severe mitochondrial inheritance and growth defects. As shown previously ([@B29]; [@B22]), ∼70% of medium and large buds in a *ypt11*Δ *mmr1*Δ strain fail to receive mitochondria from the mother cell during division. This defect can be rescued by overexpression of Ypt11 alone, providing a sensitive assay for function of this protein.

![The N-terminus of Ypt11 contributes to mitochondrial inheritance. (A) Constructs used to test codons M1 and M63 (marked with asterisks) as potential translation start sites. The *YPT11* ORF is dark gray; the thin line in *ypt11Δ62N* marks the sequence missing in this construct; noncoding regions are light gray. *P-YPT11* is the native *YPT11* promoter (see Supplemental Methods). (B, C) Quantification of mitochondrial inheritance in medium- and large-budded cells of the *mmr1*Δ *ypt11*Δ strain containing the indicated plasmids. Bars, mean and SD of three independent experiments (*n* = 100). (D) Steady-state abundance of GFP-tagged ypt11Δ62N or Ypt11 in the *mmr1*Δ*ypt11*Δ strain assayed by Western blotting using an anti-GFP antibody. I, induced; U, uninduced. Predicted molecular weights for fusion proteins are indicated.](1185fig1){#F1}

We began by mutating the initial ATG codon (Met-1) to ATC, creating ypt11-M1(ATC) ([Figure 1A](#F1){ref-type="fig"}). This construct allowed us to test whether the downstream Met63 codon could serve as a translational start site in vivo and whether the resulting protein was functional. Mitochondrial inheritance is only observed in 30--35% of *ypt11*Δ *mmr1*Δ cells containing vector alone ([Figure 1, B and C](#F1){ref-type="fig"}). This defect was fully rescued by the full-length *YPT11* gene flanked by native upstream and downstream sequence. This rescue depended on the presence of the Met-1 initiation codon, since rescue was not observed with ypt11-M1(ATC). Thus either Met-63 cannot be used as an initiation codon or the short form of Ypt11 is not functional for mitochondrial inheritance.

To test the latter possibility, we cloned the short form of *YPT11* (encoding ypt11Δ62N) downstream of the native *YPT11* or *MET25* promoter ([Figure 1A](#F1){ref-type="fig"}, bottom). ypt11Δ62N expressed from the *YPT11* promoter partially rescued mitochondrial inheritance (68% of buds contained mitochondria; [Figure 1C](#F1){ref-type="fig"}), even though a green fluorescent protein (GFP)--tagged version of the protein could not be detected by immunoblotting ([Figure 1D](#F1){ref-type="fig"}, lane 1; note that full-length Ypt11 protein expressed from the native promoter is also not detected by immunoblotting; see [Figure 2C](#F2){ref-type="fig"}). When induced from the *MET25* promoter, ypt11Δ62N abundance increased ([Figure 1D](#F2){ref-type="fig"}, compare lanes 2 and 3), and the protein fully restored mitochondrial inheritance in *ypt11*Δ *mmr1*Δ ([Figure 1C](#F1){ref-type="fig"}). Although these results demonstrate that ypt11Δ62N can promote mitochondrial inheritance, overexpression is required for full rescue, indicating that this shorter form is only partially functional. Because these findings indicate that the N-terminal 62 amino acids of Ypt11 are important for its function in mitochondrial inheritance, we used the longer form for all experiments in this study.

![Subcellular localization of Ypt11 is affected by expression level. (A, B) Representative DIC and fluorescence images of *ypt11Δ* cells expressing GFP-Ypt11 from the *MET25* promoter, grown on synthetic media with (A, uninduced) or without (B, induced) methionine. An asterisk marks the tip of a small bud; an arrowhead points to the neck between the mother cell and a large bud. Perinuclear staining is marked with arrows in B. Bar, 5 μm. (C) Expression of GFP-Ypt11 under the indicated conditions was analyzed by Western blotting using anti-GFP antibody. I, induced; U, uninduced. (D) Quantification of mitochondrial inheritance in medium- and large-budded cells of the *mmr1*Δ *ypt11*Δ strain expressing Ypt11 from the indicated promoters. Bars, mean and SD of three independent experiments (*n* = 100).](1185fig2){#F2}

ER-localized Ypt11 does not participate in mitochondrial inheritance
--------------------------------------------------------------------

To determine whether the different subcellular localizations reported for Ypt11 could be due, in part, to the presence or absence of the N-terminal extension, we investigated the localization of the longer, fully functional form of the protein. Of interest, the subcellular localization observed for this protein depended on its level of expression. GFP-Ypt11 expressed from the native *YPT11* promoter was at the limit of detection by fluorescence microscopy and could not be detected by immunoblotting (unpublished data; [Figure 2C](#F2){ref-type="fig"}). When overexpressed from the *MET25* promoter under noninducing conditions ([Figure 2C](#F2){ref-type="fig"}, *MET25*/U), GFP-Ypt11 localized to bud tips and necks, mirroring Myo2 localization ([Figure 2A](#F2){ref-type="fig"}). This localization is consistent with that previously reported for the overexpressed short form of Ypt11 ([@B30]). Induction of the *MET25* promoter ([Figure 2C](#F2){ref-type="fig"}, *MET25*/I) shifted the localization to the cER and perinuclear ER. Similar ER localization was reported previously for Ypt11 ([@B10]). Despite the fact that the only known adaptor for Ypt11, Ret2, is associated with Golgi compartments ([@B3]), we did not see a pattern resembling Golgi localization. We also did not detect Ypt11 on mitochondrial networks (compare [Figure 2, A and B](#F2){ref-type="fig"}, with Supplemental Figure S1C), although Ypt11 expressed from either the native or the *MET25* promoter was functional for mitochondrial inheritance ([Figure 2D](#F2){ref-type="fig"}). Thus Ypt11 is present on mitochondrial membranes at a very low level, or acts indirectly, via ER--mitochondrial contacts, for example, to promote mitochondrial inheritance.

To determine whether Ypt11 can influence mitochondrial inheritance from the ER, the mitochondrion, or both locations, we created localization-restricted variants of the protein. First, we removed the last three amino acids (CCV) from Ypt11, which form a prenylation site necessary for membrane targeting. The GFP-tagged form of this ypt11ΔCCV variant localized to the cytoplasm ([Figure 3A](#F3){ref-type="fig"}). Second, we replaced the Ypt11 CCV motif with the transmembrane domain of Fis1 (a tail-anchored protein of the outer mitochondrial membrane), creating ypt11-Mt. GFP-ypt11-Mt colocalized with red fluorescent protein (RFP)--labeled mitochondrial networks in yeast cells ([Figure 3B](#F3){ref-type="fig"}). Third, we replaced the Ypt11 CCV motif with the 35--amino acid C-terminal transmembrane domain of the ER protein Frt1 ([@B4]), creating ypt11-ER. GFP-ypt11-ER colocalized with RFP-labeled perinuclear ER and cER in yeast ([Figure 3C](#F3){ref-type="fig"}).

![Mitochondrial association is essential for Ypt11 function in mitochondrial inheritance. (A--C) Representative DIC and fluorescence images of *ypt11*Δ cells coexpressing GFP-tagged Ypt11 variants (uninduced *MET25* promoter) and the indicated red fluorescent protein markers. Bar, 5 μm. (D) Quantification of mitochondrial inheritance in medium- and large-budded cells of the *mmr1*Δ *ypt11*Δ strain expressing mtGFP and either WT untagged Ypt11 or its variants from the native *YPT11* promoter. Both normal distribution (black bars) and mitochondria accumulated in the bud (gray bars) were scored (black plus gray is total inheritance). (E) Same as D, except that Ypt11 variants were expressed from the *MET25* promoter under inducing conditions. (F) Expression of GFP-Ypt11 variants expressed from the *MET25* promoter was analyzed by Western blotting using anti-GFP antibody. (G) Accumulation of cER in small yeast buds was quantified in *ypt11*Δ cells coexpressing ER-dsRed and either Ypt11 or ypt11-ER (*MET25* promoter, inducing conditions). The graph shows percentage of cells displaying excessive amount of cER in the bud as compared with normal distribution during cell division. Bars, mean and SD of three independent experiments (*n* = 100).](1185fig3){#F3}

When untagged versions of these variants were expressed from the *YPT11* promoter, neither the cytoplasmic nor the ER-targeted proteins complemented the mitochondrial inheritance defect of the *ypt11*Δ *mmr1*Δ strain compared with vector alone ([Figure 3D](#F3){ref-type="fig"}). By contrast, ypt11-Mt not only rescued the defect but also was much more efficient in driving mitochondria into the bud than the wild-type (WT) protein. This effect was observed as an increase in the accumulation of excess mitochondria in yeast buds ([Figure 3D](#F3){ref-type="fig"}, gray bars, and Supplemental Figure S1, A and B). Although the phenomenon was also observed to some extent in cells expressing WT Ypt11 (4%), the effect was more pronounced in cells expressing ypt11-Mt (28%).

Additional control studies were performed to verify that the ypt11-ER protein was expressed and that the Frt1-derived transmembrane domain did not interfere with protein\'s activity. Although *MET25*-overexpressed GFP-ypt11-ER could be detected by immunoblotting ([Figure 3F](#F3){ref-type="fig"}), the protein was not functional for mitochondrial inheritance (only 31% of buds contained mitochondria; [Figure 3E](#F3){ref-type="fig"}). Conversely, overexpression of ypt11-Mt or Ypt11 from the *MET25* promoter rescued the inheritance defect fully and induced the mitochondrial accumulation phenotype in which excess organelles accumulate in the bud (in 56 and 21% of budded cells, respectively; [Figure 3E](#F3){ref-type="fig"}, gray bars). The fact that ypt11-ER is less abundant than WT Ypt11 (threefold lower; [Figure 3F](#F3){ref-type="fig"}) does not explain its inability to rescue mitochondrial inheritance. Even though ypt11-Mt steady-state levels were 10-fold lower than the WT protein ([Figure 3F](#F3){ref-type="fig"}), its function in mitochondrial inheritance was 2.5-fold higher.

WT Ypt11 has also been shown to mediate cER inheritance during yeast budding ([@B10]; [@B22]). We verified that this activity had not been compromised by irreversibly tethering Ypt11 to the ER. When overexpressed from the *MET25* promoter, ypt11-ER caused the accumulation of cER in yeast buds, similar to WT Ypt11 ([Figure 3G](#F3){ref-type="fig"}). Thus addition of an ER transmembrane anchor to Ypt11 did not disrupt the protein\'s ER inheritance function. Our combined results demonstrate that Ypt11 localized to the ER cannot drive mitochondrial inheritance and suggest that Ypt11 needs to be localized to mitochondria to perform that function.

Rab characteristics of Ypt11 are essential for mitochondrial inheritance
------------------------------------------------------------------------

Comparison of the Ypt11 sequence with other Rab proteins singles it out as a unique family member. Several stretches of the Ypt11 sequence either are not found or are much longer than those in other Rabs. In addition to the unusually long N-terminal extension ([Figure 4A](#F4){ref-type="fig"}, region I), Ypt11 contains an 83-aa insert separating the P-loop from the switch I region of the GTPase ([Figure 4A](#F4){ref-type="fig"}, region II). In addition, the C-terminal unstructured region is significantly longer in Ypt11 than in other Rabs ([Figure 4A](#F4){ref-type="fig"}, region III). As a result of these additions, Ypt11 is twice as long (417 aa) as a typical Rab (200+ aa). However, all GTPase and Rab-specific motifs ([Figure 4A](#F4){ref-type="fig"}, G1-G3, PM1-PM3, and RabF1-5) can be identified in Ypt11 with significant conservation of these regions of the protein.

![Multiple sequence alignment of Ypt11 with fungal and mammalian Rabs. (A) The alignment highlights similarities and differences between *S. cerevisiae* Ypt11 and other members of the Rab superfamily. Sequences unique to Ypt11 and excluded from the alignment are marked I (for the N-terminal extension) and II (for an insert within the switch I region of the GTPase). The highly variable C-terminal region (III) is significantly longer in Ypt11 orthologues than in other Rabs. Numbers in parentheses in the alignment denote the number of amino acids hidden from view. The positions of the conserved GTPase motifs for nucleotide binding (PM1-3 required for phosphate and/or Mg^2+^ binding; G1-3 required for guanine binding), Rab-family signature motifs (RabF1-5; [@B42]), and the geranyl-geranylation site (GG site) are indicated above the alignment. Asterisks mark residues changed in the GTPase-domain mutants ypt11(T104N) and ypt11(Q232L). (B) Alignment of fungal Ypt11 sequences that are conserved in regions marked I and II in A. Serine residues (S8, S77, S79, S80, S158, S159) mutated to alanine in this study are marked with asterisks. Residues shaded black are identical, and those shaded gray are similar. Ag, *Ashbya gossypii*; Cg, *Candida glabrata*; Hs, *Homo sapiens*; Kl, *Kluyveromyces lactis*; Lt, *Lachancea thermotolerans*; Sc, *S. cerevisiae*; Sk, *Saccharomyces kluyveri*; Sm, *Saccharomyces mikatae*; Sp, *Saccharomyces paradoxus*; Zr, *Zygosaccharomyces rouxii*.](1185fig4){#F4}

Several mutations are known to affect the GTPase activities of Ras and Rabs. Although predicted inactivating mutations in the Ypt11 GTPase domain have been analyzed ([@B30]), activating mutations have not been studied. To address this issue, we replaced the glutamine in the switch II region, which coordinates a water molecule during GTP hydrolysis, with a leucine residue ([Figure 4A](#F4){ref-type="fig"}, motif PM3, ypt11(Q232L)). As a negative control, we created a ypt11(T104N) mutant. The substitution of asparagine for serine/threonine in the P-loop ([Figure 4A](#F4){ref-type="fig"}, motif PM1) is predicted to cause preferential GDP binding, inactivating the downstream signaling by Ras and Rab proteins ([@B56]; [@B53]). As expected, the ypt11(T104N) mutant protein was unable to rescue the mitochondrial inheritance defect ([Figure 5A](#F5){ref-type="fig"}, black bars), even though the protein was expressed ([Figure 5B](#F5){ref-type="fig"}). Of interest, the steady-state abundance of the inactive protein was much higher than that of the WT protein. This was the first indication that the cellular abundance of Ypt11 might be linked to (and constrained by) its activity, an idea we test in greater detail later in this study.

![Rab properties of Ypt11 are important for mitochondrial inheritance. (A) Mitochondrial inheritance was quantified in *mmr1*Δ *ypt11*Δ cells expressing either WT Ypt11 or the GTPase-mutant variants from *MET25* promoter under inducing conditions. Both normal distribution (black bars) and mitochondria accumulated in the bud (gray bars) were scored (black plus gray is total inheritance). (B) Expression of FLAG-tagged Ypt11 variants (51.8 kDa) from the *MET25* promoter analyzed by Western blotting using anti-FLAG antibody. The asterisk marks a slower-migrating molecular weight species predicted to be the phosphorylated form of the protein. (C) Quantification of the mitochondrial accumulation phenotype in WT cells expressing either Ypt11 or ypt11(Q232L) mutant from the native *YPT11* promoter. \**p* \< 0.005 in Student\'s *t* test. (D) Interaction of WT and mutant Ypt11 variants with the Myo2 tail (Myo2^t^, left) or Mmr1 (right) was tested using a two-hybrid assay on SD‑Leu-Trp-His medium containing 10 mM (Myo2^t^) or 2 mM (Mmr1) 3-AT. Bars, mean and SD of three independent experiments (*n* = 100; A, C).](1185fig5){#F5}

The ypt11(Q232L) allele rescued the mitochondrial inheritance defect fully, indicating that the protein is active ([Figure 5A](#F5){ref-type="fig"}). Although overexpression of ypt11(Q232L) also promoted accumulation of mitochondria in buds ([Figure 5A](#F5){ref-type="fig"}, gray bars), the extent of this effect was similar to that caused by overexpression of WT Ypt11. This result suggested that ypt11(Q232L) was not a constitutively active protein, as a more pronounced accumulation phenotype would be expected in this case. To test whether differences between ypt11(Q232L) and Ypt11 were masked by overexpression, we analyzed the accumulation phenotype in *ypt11*Δ cells expressing either protein from the native *YPT11* promoter. This assay showed a small but statistically significant difference between ypt11(Q232L) and WT Ypt11 activity ([Figure 5C](#F5){ref-type="fig"}). Although neither WT Ypt11 ([Figure 2C](#F2){ref-type="fig"}) nor ypt11(Q232L) (unpublished results) could be detected by Western blotting when expressed from the *YPT11* promoter, *MET25*-expressed ypt11(Q232L) had a higher steady-state abundance than WT Ypt11 ([Figure 5B](#F5){ref-type="fig"}). Thus differences in the mitochondrial accumulation phenotypes noted in [Figure 5C](#F5){ref-type="fig"} are likely caused by differences in protein abundance rather than intrinsic differences in activities of the proteins.

Consistent with the observation that ypt11(Q232L) is active in mitochondrial inheritance, the mutant protein interacted with the Myo2 tail in a yeast two-hybrid assay ([Figure 5D](#F5){ref-type="fig"}), similar to WT Ypt11 ([@B30]; [Figure 5D](#F5){ref-type="fig"}). By contrast, the T104N mutation abolished the interaction with Myo2. Of importance, we identified a novel interaction of Ypt11 with Mmr1 ([Figure 5D](#F5){ref-type="fig"}; note that the Ypt11--Mmr1 interaction was not as robust as that between Ypt11 and Myo2 and was more sensitive to the presence of 3‑aminotriazole in the medium). This interaction also required a functional Ypt11 GTPase domain, since Mmr1 binding occurred with the Q232L but not the T104N allele.

Our combined results establish that a functional Ypt11 GTPase domain is important for interaction with two distinct binding partners needed for mitochondrial inheritance. Moreover, tethering Ypt11 to the membrane enhances its effect on mitochondrial distribution significantly more than a mutation predicted to lock the enzyme in the GTP-bound state (compare [Figures 3E](#F3){ref-type="fig"} and [5A](#F5){ref-type="fig"}). Our data also suggest that less active forms of Ypt11 are maintained in the cell at a higher steady-state level than active forms.

A conserved phosphorylation site controls Ypt11 abundance in cells
------------------------------------------------------------------

Phosphorylation has been shown to regulate the membrane localization or effector interactions of a handful of yeast and mammalian Rabs ([@B57]; [@B19]; [@B15]; [@B25]). Our immunoblotting studies reproducibly showed a weaker upper protein band migrating close to the predominant Ypt11 species, suggesting that this Rab might also be phosphorylated (see [Figures 5B](#F5){ref-type="fig"} and [6A](#F6){ref-type="fig"}, asterisk). We used a phosphatase assay in combination with a Phos-tag gel system to test whether the high--molecular weight Ypt11 species were phosphoproteins. As shown in [Figure 6A](#F6){ref-type="fig"}, the slower-migrating species were reduced or disappeared completely when extracts from cells expressing WT Ypt11 were treated with phosphatase. In addition, the main protein band shifted to a lower molecular weight upon CIP treatment in all samples ([Figure 6A](#F6){ref-type="fig"} and Supplemental Figure S2), suggesting that Ypt11 is constitutively phosphorylated in vivo. We also noticed that the extent and pattern of phosphorylation was different for the inactive, cytoplasmic variant ypt11ΔCCV, with the major dephosphorylated band migrating faster than the equivalent WT Ypt11 protein. This altered mobility is not a consequence of the C-terminal amino acid deletion in ypt11ΔCCV, since we observed the same pattern for the inactive ypt11(T104N) mutant form of the full-length protein (Supplemental Figure S2). Thus WT Ypt11 is likely subject to additional posttranslational modification(s) in addition to phosphorylation.

![A conserved phosphorylation site modulates Ypt11 abundance. (A) Whole-cell extracts from *ypt11*Δ cells expressing FLAG-Ypt11 or FLAG-ypt11ΔCCV from the *MET25* promoter were incubated with or without calf alkaline phosphatase (CIP). Samples were separated in 16-cm 8% acrylamide (left) or 8% acrylamide + Phos-tag minigels (right), and Ypt11 bands were visualized by anti-FLAG immunoblotting. Threefold less material was loaded for ypt11ΔCCV samples. Arrowheads mark the presumed dephosphorylated protein bands; asterisks mark modified species. (B) Interaction of serine-to-alanine Ypt11 variants with Myo2 tail (Myo2^t^) and Mmr1 was tested using a two hybrid assay. Fivefold serial dilutions were spotted on SD‑Leu-Trp-His and incubated for 2 d at 30°C. (C) Quantification of mitochondrial accumulation in buds of *ypt11*Δ cells overexpressing WT Ypt11 and the indicated serine-to-alanine variants from the *MET25* promoter. Results are normalized to WT. Bars, mean and SD of three independent experiments (*n* = 100). Student\'s *t* test: S8A, *p* \< 0.05; S158A, *p* \< 0.001; S158A,S159A, *p* \< 0.001; 5xS/A, *p* \< 0.001). (D) The expression of FLAG-Ypt11 or FLAG-ypt11(S158A,S159A) in *ypt11*Δ cells analyzed by anti-FLAG Western blotting. Two replicates are shown for each protein. A nonspecific band reacting with anti-FLAG antibody (marked with x) was used as a loading control. Bottom, a shorter exposure of the nonspecific band. 2xS/A = ypt11(S158A,S159A); 3xS/A = ypt11(S8A,S158A, S159A); 5xS/A = ypt11(S77A,S79A,S80A,S158A, S159A); 6xS/A = ypt11(S8A,S77A,S79A,S80A,S158A, S159A).](1185fig6){#F6}

The multiple high--molecular weight species observed in the untreated WT Ypt11 extract ([Figure 6A](#F6){ref-type="fig"}) may indicate that multiple sites are phosphorylated in the protein. Alternatively, Ypt11 proteins with differing phosphorylation status at individual sites may coexist in the cell. Phosphorylation prediction algorithms (NetPhos, [@B6]; DISPHOS, [@B28]; pkaPS, [@B39]) detected a number of potential phosphorylation sites in Ypt11. Two of these (S77, S158--S159) were identified by mass spectrometry ([@B1]; [@B7], [@B8]; [@B26]). Residues S158 and S159 lie within a unique Ypt11 insert and are part of an RKRYS motif conserved among fungi ([Figure 4B, II](#F4){ref-type="fig"}). A similar motif (containing S8) is found in the N-terminal extension specific for Ypt11 ([Figure 4B, Ia](#F4){ref-type="fig"}). Although the region surrounding S77 is not conserved, it contains several serine residues with high phosphorylation-prediction scores, which we included in our analysis (S77, S79, S80; [Figure 4B, Ib](#F4){ref-type="fig"}).

We used the two-hybrid assay to evaluate the effect of phosphorylation-site mutation(s) on Ypt11 effector interactions. Even when a serial dilution assay was applied to test for subtle differences in growth rates, none of the mutant proteins, including the one combining all six sites (S8A, S77A, S79A, S80A, S158A, S159A), exhibited interaction defects with the Myo2 tail or Mmr1 ([Figure 6B](#F6){ref-type="fig"}). In spite of this, some of the substitutions decreased Ypt11's ability to promote mitochondrial accumulation in buds when overexpressed ([Figure 6C](#F6){ref-type="fig"}). The strongest defect was observed for the ypt11(S158A,S159A) double mutant. However, this mutant was significantly less abundant than the WT protein ([Figure 6D](#F6){ref-type="fig"}). Thus the decrease in mitochondrial accumulation phenotypes for both mutant proteins ([Figure 6C](#F6){ref-type="fig"}) is probably due to their decreased abundance. The fact that we observed slower-migrating bands for ypt11(S158A,S159A) (and the 5xS/A ypt11 mutant; unpublished results) in separating gels suggests that Ypt11 may be phosphorylated on some lower-probability sites that were not included in our analysis.

Taken together, our findings demonstrate that Ypt11 is a phosphoprotein. For the sites we queried, Ypt11's phosphorylation status does not affect its interaction with effectors required for mitochondrial inheritance. However, mutation of predicted phosphorylation sites decreases Ypt11 abundance, suggesting that this modification plays a role in regulating Ypt11 availability in the cell.

Ypt11 activity and abundance are tightly linked
-----------------------------------------------

We and others showed previously that overexpression of WT Ypt11 is lethal in yeast, in part because excessive mitochondrial transport depletes mitochondria from the mother cell ([@B30]; [@B22]). We found that Ypt11-variant abundance and activity are inversely correlated when proteins are overexpressed from the *MET25* promoter (high abundance: ypt11ΔCCV and ypt11(T104N) \>\> ypt11(Q232L) ≥ WT Ypt11 \>\>\> ypt11-Mt: low abundance; Supplemental Figure S3). Thus the pool of active Ypt11 appears to be tightly regulated. A scenario in which active forms of the protein are rapidly turned over to prevent their accumulation could explain these results. To test this idea, we analyzed protein stability under conditions in which translation was blocked by cycloheximide (CHX). As shown in [Figure 7](#F7){ref-type="fig"}, degradation of active variants WT Ypt11 and ypt11-Q232L occurred in the first 30 min of the experiment, although a fraction of the protein lingered throughout the 2-h time course. By contrast, the inactive cytoplasmic variant ypt11ΔCCV was stable throughout the time course. The very low abundance of the ypt11-Mt variant prevented its analysis by this method. These CHX-chase experiments confirmed that active variants of the protein are maintained at a lower level in cells and indicate that this is achieved through degradation.

![Ypt11 abundance is controlled by degradation. FLAG-tagged Ypt11 and mutant variants were expressed from the *MET25* promoter in the *ypt11*Δ strain. Protein stability was assessed in whole-cell extracts prepared at the indicated time points after addition of cycloheximide. Ypt11 variants and a phosphoglycerate kinase (PGK) loading control were detected by immunoblotting with anti-FLAG or anti-PGK antibodies. See *Materials and Methods* for details.](1185fig7){#F7}

Although the behavior of inactive ypt11ΔCCV is entirely consistent with our model (the protein is not degraded), the results for inactive ypt11(T104N) are less straightforward. Although ypt11(T104N) was degraded in the presence of CHX, the abundance of ypt11(T104N) at the start of the chase was similar to that of ypt11ΔCCV. These findings are consistent with the idea that inactive Ypt11 variants are less deleterious to the cell and can be tolerated at higher steady-state abundance.

As shown in [Figure 8A](#F8){ref-type="fig"}, overexpressed ypt11(T104N) is predominantly cytoplasmic. However, this variant contains the C-terminal prenylation site and has the potential to interact with membranes. We introduced the T104N mutation into ypt11-Mt to test whether membrane association (in addition to protein activity) determines protein abundance in cells. In contrast to the nontethered form, ypt11-Mt(T104N) localized exclusively to mitochondria ([Figure 8A](#F8){ref-type="fig"}). Similar to the inactive ypt11(T104N) and ypt11ΔCCV variants, overexpression of ypt11-Mt(T104N) did not induce mitochondrial accumulation in buds ([Figure 8B](#F8){ref-type="fig"}). Despite its membrane localization, the abundance of ypt11-Mt(T104N) remained high, similar to that of the inactive ypt11(T104N) and ypt11ΔCCV proteins ([Figure 8C](#F8){ref-type="fig"}). Thus the localization of ypt11-Mt(T104N) to membranes is not sufficient to decrease its abundance in the cell.

![Membrane targeting does not control the abundance of ypt11(T104N). (A) Representative DIC and fluorescence images of *ypt11Δ* cells expressing GFP-tagged Ypt11 and mutant variants from the *MET25* promoter. Bar, 5 μm. (B) Quantification of the mitochondrial accumulation phenotypes in *ypt11*Δ cells expressing mtGFP and the indicated Ypt11 variants. Bars, mean and SD of three independent experiments (*n* = 100). (C) Whole-cell extracts from *ypt11*Δ cells expressing FLAG-tagged Ypt11 variants from the *MET25* promoter were analyzed by Western blotting using anti-FLAG antibody. Two exposures of the same membrane are shown.](1185fig8){#F8}

DISCUSSION
==========

Our studies advance the understanding of key aspects of Ypt11 function. First, our findings provide an explanation for the different subcellular localizations reported for Ypt11 in the literature. Second, we provide evidence that direct association of Ypt11 with mitochondria is essential for its role in mitochondrial inheritance. Third, we demonstrate that ER-localized Ypt11 cannot support mitochondrial inheritance, arguing against the idea that ER--mitochondrial contacts allow passive movement of mitochondria during polarized ER transport. Fourth, we show that Ypt11 function is regulated at multiple levels. The C-terminal prenylation motif in Ypt11, which controls its membrane association, is required for its mitochondrial inheritance function. The Ypt11 GTPase cycle controls interaction with Myo2 and a novel interacting partner, Mmr1. In addition, active forms of Ypt11 are selectively degraded in vivo. Finally, Ypt11 is a phosphoprotein. We show that a conserved phosphorylation motif within a unique Ypt11 insert regulates its cellular abundance.

The function of Ypt11 in organelle inheritance has been assigned, in part, by in vivo localization studies ([@B30]; [@B10]). Ypt11 is expressed at very low levels from its native promoter and cannot be definitively localized. When highly overexpressed, Ypt11 clearly localizes to the perinuclear and cortical ER ([@B10]; this study). The physiological relevance of this localization is supported by studies showing that Ypt11 promotes cER inheritance ([@B10]; [@B22]; [@B54]) and can drive excess cER into buds ([@B22]). Collins and colleagues have shown that Ypt11 interacts with a host of ER- and Golgi-associated membrane proteins, which bind a broad range of yeast Rabs ([@B11]; [@B12]). The availability of less specific binding partners at the ER may explain why this localization predominates when Ypt11 is highly overexpressed in cells. The identification of Ret2 as an adaptor for Ypt11 validated the Golgi as a physiological target for this Rab ([@B3]). Nevertheless, clear Golgi localization of Ypt11 is not observed at endogenous expression levels or after overexpression ([@B3]; this study). As shown by us and others ([@B30]; [@B22]), there is compelling evidence that Ypt11 acts on mitochondrial membranes to promote inheritance, even though fluorescence imaging studies have not revealed Ypt11 on these compartments. This inability to detect Ypt11 at cellular membranes where it clearly functions may reflect a transient interaction of Ypt11 at these sites or a requirement for very few molecules of Ypt11 to exert its function. Alternatively, Ypt11 could act indirectly on mitochondria from another cellular locale, as will be discussed.

If Ypt11 directly transports ER membranes, mitochondria could be moved indirectly via stable ER--mitochondrial contact sites. We previously showed that one such linkage (formed by the ERMES complex) was not essential for mitochondrial inheritance, since overexpression of Ypt11 partially rescued mitochondrial transmission to buds in ERMES mutants ([@B40]). These findings established that ERMES contact sites are not required for Ypt11 action on mitochondria but did not rule out the possibility that Ypt11 might mediate tandem organelle transport through other types of ER--mitochondrial linkages. We tested this idea by expressing an ER-tethered form of Ypt11. Although Ypt11-ER was active and promoted cER transport, it was unable to rescue mitochondrial inheritance defects in *ypt11Δ mmr1Δ*. Thus it is unlikely that Ypt11 acts from the ER membrane to promote mitochondrial movement into buds.

Recent studies outlined how a yeast Rab cascade regulates Myo2 binding and transport of cargo through the secretory pathway ([@B32]; [@B48]; [@B16]). Based on its involvement in cER inheritance ([@B10]; [@B22]) and late Golgi transport ([@B3]), Ypt11 could act early in this cascade to help deliver cargo to the growing bud. It has been proposed that, instead of recruiting Myo2 to mitochondria, Ypt11 mediates bud-directed transport of ER- and Golgi-associated factor(s) that retain mitochondria in the daughter cell once they arrive ([@B9]; [@B44]). If this was the case, the ypt11-ER construct should enhance delivery of this factor(s) to buds and indirectly improve mitochondrial inheritance. However, this did not occur. Although ER-anchored Ypt11 was active and caused accumulation of cER in buds, mitochondrial bud accumulation was not observed. We favor a model in which Ypt11-dependent, bud-directed transport relies on localization of a fraction of this Rab GTPase to mitochondria. This model is supported by our finding that Ypt11 tethered to mitochondria promotes mitochondrial inheritance and the observation that Myo2 localizes to the surface of mitochondria ([@B20]). Although it is clear that mitochondria transported from the mother cell are retained at the bud tip ([@B60]) and that this is critical for successful mitochondrial inheritance, the components required for this anchoring step are only beginning to be identified ([@B54]).

Rab GTP binding and hydrolysis control the effector interactions through which Rabs carry out their cellular functions. Our study is the first to analyze a putative activating allele of Ypt11. Of interest, the ypt11(Q232L) allele maintains mitochondrial inheritance activity but does not behave as a constitutively activated protein, which would be expected to significantly enhance organelle accumulation in buds. This finding is not necessarily unexpected, since the effect of the Q-to-L mutation is less predictable in Rabs than for the prototypical Ras GTPase. A similar mutation in the secretory Rab Ypt1 reduced GTP hydrolysis of the protein but did not cause the predicted dominant phenotype ([@B47]). A corresponding mutation in Sec4 blocks its GTP hydrolysis ability but has a negative rather than positive effect on its function ([@B58]). Only active Ypt11 was able to interact with the Myo2 tail, consistent with the idea that Ypt11-GTP binds the motor and GTP hydrolysis releases the motor (this study and [@B30]). Of importance, we found that Mmr1, the only other known Myo2-binding partner involved in mitochondrial inheritance, can also interact with Ypt11. The interaction with Mmr1 was also restricted to active forms of Ypt11 (WT and Q232L). The binding sites for Mmr1 and Ypt11 on Myo2 do not overlap and lie on opposite sides of the Myo2 cargo-binding domain ([@B17]). Thus the Ypt11--Mmr1 interaction could be direct or could reflect simultaneous binding of both proteins to Myo2. In either case, Ypt11 and Mmr1 might act together or sequentially to modulate mitochondrial binding to Myo2 or the activity of the Myo2 motor. Sequential functions for Ypt11 and Mmr1 seem more likely since Ypt11 is expressed early in G1 of the cell cycle, whereas Mmr1 transcription peaks at the G2/M transition ([@B14]; [@B52]; [@B45]).

The finding that active forms of Ypt11 are subject to degradation was unexpected. The lethal effects of WT Ypt11 overexpression are an indication that cells need to tightly control the abundance of this Rab. Although Ypt11 expression is regulated at the transcriptional level ([@B14]; [@B52]; [@B45]), degradation provides an additional mechanism to posttranslationally fine tune protein abundance. Ypt11 degradation may occur constitutively or selectively in the bud after the Rab has completed its function in organelle inheritance. The latter scenario would be similar to the degradation reported for the Myo2 vacuole adaptor Vac17 after bud delivery ([@B55]). To our knowledge, this is the first report of selective degradation of active forms of a Rab.

We identified an 84--amino acid insert in Ypt11 orthologues that is not found in other Rabs. The localization of the insert, directly upstream of the critical switch I region in Rabs, suggested it might affect binding partner interactions ([@B38]; [@B43]; [@B13]; [@B59]). Highly conserved residues within this insert form a predicted phosphorylation motif common among substrates of Ca^2+^-calmodulin and PKA kinases. However, mutation of these predicted phosphorylation sites had no effect on Myo2 or Mmr1 binding. Instead, these mutations significantly decreased Ypt11 protein abundance. It is possible that phosphorylation at these sites stabilizes Ypt11 during key stages of the cell cycle. In addition, this phosphorylation could regulate Ypt11 interactions with binding partners other than Myo2 and Mmr1.

On the basis of our new findings, we propose a working model for Ypt11-mediated mitochondrial inheritance ([Figure 9](#F9){ref-type="fig"}). Borrowing from what is known about the regulation of other Rabs, the model indicates that Ypt11-GDP is recruited from the cytoplasm to the mitochondrial surface. Subsequent interaction with an unknown exchange factor converts the Rab to its GTP-bound form, promoting binding to the Myo2 motor tail and bud-directed mitochondrial transport. Phosphorylation of Ypt11 after membrane recruitment might stabilize Ypt11 and prevent degradation during mitochondrial inheritance. After mitochondrial delivery to the tip of the bud, Ypt11 dephosphorylation and degradation would remove Ypt11 (and Myo2) from the membrane and release mitochondria from the anchoring site at the bud tip. This would allow the organelle to interact with downstream factors that spread the network at the cell cortex as bud growth shifts from apical to isotropic expansion mode. In the future, this model will provide an important framework for testing and ordering critical Ypt11 functions required for polarized mitochondrial movement.

![Multiple inputs combine to regulate availability of the active Ypt11 GTPase for mitochondrial inheritance. A working model. The ability of Ypt11 to associate with mitochondrial membranes (1) and interact with Myo2 in a GTP-dependent manner (2) is a prerequisite for its function in mitochondrial inheritance. Phosphorylation of serines 158 and 159 is not essential for mitochondrial inheritance. Instead, phosphorylation of the active protein on these (and perhaps other) sites occurs after membrane targeting and stabilizes the membrane-bound complex (3). As shown in this study, membrane association is not sufficient for degradation of the inactive GTPase. Thus both membrane association and a functional GTPase domain are required for Ypt11 degradation and a return to low steady-state abundance (4). Because active, membrane-associated Ypt11 is required to complete mitochondrial bud delivery, it seems likely that the protein is targeted for degradation after its inheritance function is completed (5). Consistent with this interpretation, we observed that Ypt11 variants that cannot mediate mitochondrial inheritance (either due to a defective GTPase domain or the inability to bind membranes) are not deleterious to the cell and are not targeted for selective degradation.](1185fig9){#F9}

MATERIALS AND METHODS
=====================

Yeast strains and plasmid construction
--------------------------------------

The yeast strains used in this study were created in the W303 genetic background (*ade2-1 leu2-3 his3-11,15 trp1-1 ura3-1 can1-100*) and are listed in Supplemental Table S1. All mutations, disruptions, and constructs were confirmed by PCR and DNA sequencing. Construct generation is described in Supplemental Methods, and the plasmids used in this study are listed in Supplemental Table S2. Standard methods were used for transformation and growth of *S. cerevisiae* ([@B50]; [@B24]) and *Escherichia coli* ([@B35]).

Microscopy and imaging
----------------------

Cells were visualized by an Axioplan 2 microscope equipped with Zeiss Plan-Apochromat 100×/numerical aperture 1.4 objective (Carl Zeiss, Jena, Germany) and differential interference contrast (DIC) optics. Images were captured using a monochrome camera (AxioCam Mm; Carl Zeiss) and AxioVision 3.1 software and assembled using Photoshop (Adobe, San Jose, CA) with linear adjustments of brightness and contrast applied. Organelle markers used in this study were Su9(1-69)-GFP or Su9(1-69)-RFPff (referred to as mtGFP or mtRFP, respectively) for mitochondria and DsRed-HDEL (ER-DsRed) for the endoplasmic reticulum.

Mitochondrial inheritance assays
--------------------------------

The inheritance of mitochondria labeled with mtGFP was quantified in medium- and large-budded cells in cultures grown to logarithmic phase in synthetic dextrose (SD) media as described previously ([@B22]). For Ypt11 overexpression experiments strains were grown overnight at 30°C in SD media lacking appropriate amino acids for selection and containing 0.085 mg/ml methionine. Ypt11 expression was induced for 30 min or 2 h by transferring cells into SD medium lacking methionine. Mitochondrial accumulation phenotype is defined as the presence of a disproportionately large amount of mitochondria in the bud ([@B22]).

Protein expression analysis
---------------------------

Whole-cell extracts were prepared by incubating cells in 0.1 M NaOH (100 μl per 1 OD~600~ unit of cells) on ice for 10 min. Cells were pelleted, resuspended in SDS--PAGE loading buffer, and boiled ([@B34]). Unless otherwise indicated, samples (extract volume equivalent to 0.2--0.5 OD~600~ unit of cells per lane for WT Ypt11, amounts adjusted as needed for mutants) were run in 10% acrylamide minigels under standard conditions. Membranes were decorated with mouse monoclonal antibodies generated against FLAG (Agilent Technologies/Stratagene, Santa Clara, CA), GFP (Covance, Berkeley, CA), and 3-phosphoglycerate kinase (Molecular Probes, Eugene, OR), followed by a goat anti-mouse immunoglobulin G (IgG)--peroxidase (Sigma-Aldrich, St. Louis, MO) or IRDye 800CW donkey anti-mouse IgG (LI-COR Biosciences, Lincoln, NE) secondary antibody. Signal was detected using ECL Plus (Thermo Scientific/Pierce, Rockford, IL) or a digital imaging system (Odyssey; LI-COR Biosciences). Quantitative analysis was performed using ImageJ software (National Institutes of Health, Bethesda, MD).

Protein stability assay (cycloheximide block)
---------------------------------------------

We collected 20 OD units of cells grown in SD medium to mid--logarithmic phase, resuspended them in SD lacking methionine, and incubated them with shaking for 30 min to induce *YPT11* overexpression. To stop induction, cells were washed once with water and resuspended in SD medium (0.5 mg/ml methionine). Cycloheximide was added to 200 μg/ml, and aliquots equal to 1 OD~600~ unit were collected at indicated time points and processed as described.

Phosphatase treatment
---------------------

Protein extraction and dephosphorylation reactions were performed as described previously ([@B41]; [@B18]) with minor modifications. Yeast were grown to mid--logarithmic phase and switched to medium lacking methionine for 30 min, and 20 OD~600~ units of cells were collected. Cells were resuspended in 1 ml of ice-cold 0.2 M NaOH and 0.5% 2-mercaptoethanol (2-ME) and incubated on ice for 10 min. Trichloroacetic acid (TCA) was added to 5% final concentration, followed by 15-min incubation on ice. Protein pellets were collected by centrifugation (10 min, 14,000 × *g*, 4°C) and resuspended in 140 μl of buffer S (0.3 M sorbitol, 10 mM Tris, pH 7.5, 0.1 M NaCl) plus 60 μl of 1 M Tris base, 133.4 μl 10% SDS, and 7 μl or 2-ME. For alkaline phosphatase treatment, 100 μl of precleared lysates and 30 U of calf intestine phosphatase (CIP; New England Biolabs, Ipswich, MA) were added to tubes containing 900 μl of NEB3 buffer (1× in final volume; New England Biolabs). Reactions were incubated for 1.5 h at 37°C and terminated by adding 50% TCA (15% final concentration), followed by 20 min of incubation on ice. Protein pellets were dissolved in 100 μl of 2× SDS loading buffer (150 mM Tris, pH 6.8, 15% glycerol, 2% SDS, 4% 2-ME, and bromophenol blue) and 20 μl of 1 M Tris base. Aliquots equivalent to 1 OD~600~ unit of starting material were loaded on 8% polyacrylamide gel (30:1 acrylamide:bisacrylamide ratio) containing 50 μg/ml Phos-tag acrylamide (Nard Institute, Amagasaki, Japan) and 10 mM MnCl~2~, followed by immunoblotting with mouse anti-FLAG antibody (Agilent Technologies/Stratagene).

Two-hybrid assay
----------------

*MMR1*, *YPT11*, or its variants were PCR amplified and cloned into pGAD-c1 and pGBD-c1 ([@B31]). The two-hybrid tests were performed in the yeast strain PJ69-4A, which contains *HIS3*, *ADE2*, and *lacZ* as chromosomally integrated reporter genes. Interactions shown were tested by plating on a solid dropout medium agar without histidine containing 3-amino-1,2,4-triazole (2 and 10 mM for Mmr1 and Myo2t interaction, respectively). BD-Mmr1 fusion was not functional (lack of interaction with AD-Myo2), and thus only interactions with Ypt11 fused to the binding domain are shown.
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